C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation
Open Access
- 16 December 2014
- journal article
- review article
- Published by Hindawi Limited in International Scholarly Research Notices
- Vol. 2014, 1-11
- https://doi.org/10.1155/2014/653045
Abstract
Cardiovascular disease is the leading cause of morbidity and mortality in the adult population worldwide, with atherosclerosis being its key pathophysiologic component. Atherosclerosis possesses a fundamental chronic inflammatory aspect, and the involvement of numerous inflammatory molecules has been studied in this scenario, particularly C-reactive protein (CRP). CRP is a plasma protein with strong phylogenetic conservation and high resistance to proteolysis, predominantly synthesized in the liver in response to proinflammatory cytokines, especially IL-6, IL-1β, and TNF. CRP may intervene in atherosclerosis by directly activating the complement system and inducing apoptosis, vascular cell activation, monocyte recruitment, lipid accumulation, and thrombosis, among other actions. Moreover, CRP can dissociate in peripheral tissue—including atheromatous plaques—from its native pentameric form into a monomeric form, which may also be synthesized de novo in extrahepatic sites. Each form exhibits distinct affinities for ligands and receptors, and exerts different effects in the progression of atherosclerosis. In view of epidemiologic evidence associating high CRP levels with cardiovascular risk—reflecting the biologic impact it bears on atherosclerosis—measurement of serum levels of high-sensitivity CRP has been proposed as a tool for assessment of cardiovascular risk.Keywords
Funding Information
- Technological, Humanistic, and Scientific Development Council (CC-0437-10-21-09-10, FZ-0058-2007)
This publication has 116 references indexed in Scilit:
- Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 ReceptorPLOS ONE, 2013
- C-reactive protein (CRP) aptamer binds to monomeric but not pentameric form of CRPAnalytical and Bioanalytical Chemistry, 2011
- Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cellsBasic Research in Cardiology, 2011
- Statin Therapy in Metabolic Syndrome and Hypertension Post-JUPITER: What is the Value of CRP?Current Atherosclerosis Reports, 2010
- Role of C-Reactive Protein in Contributing to Increased Cardiovascular Risk in Metabolic SyndromeCurrent Atherosclerosis Reports, 2010
- The membrane attack complex of complement drives the progression of atherosclerosis in apolipoprotein E knockout miceMolecular Immunology, 2010
- The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pHClinica Chimica Acta; International Journal of Clinical Chemistry, 2009
- Fcγ receptors: structure, function and role as genetic risk factors in SLEGenes & Immunity, 2009
- C-reactive protein decreases endothelial nitric oxide synthase activity via uncouplingJournal of Molecular and Cellular Cardiology, 2007
- C-Reactive Protein, Inflammatory Conditions, and Cardiovascular Disease RiskThe American Journal of Medicine, 2007